266 related articles for article (PubMed ID: 15492996)
1. Utility of immunohistochemistry for alpha-methylacyl-CoA racemase in distinguishing atrophic prostate cancer from benign atrophy.
Farinola MA; Epstein JI
Hum Pathol; 2004 Oct; 35(10):1272-8. PubMed ID: 15492996
[TBL] [Abstract][Full Text] [Related]
2. Alpha-methylacyl-CoA racemase: a variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy.
Magi-Galluzzi C; Luo J; Isaacs WB; Hicks JL; de Marzo AM; Epstein JI
Am J Surg Pathol; 2003 Aug; 27(8):1128-33. PubMed ID: 12883245
[TBL] [Abstract][Full Text] [Related]
3. Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.
Sung MT; Jiang Z; Montironi R; MacLennan GT; Mazzucchelli R; Cheng L
Hum Pathol; 2007 Feb; 38(2):332-41. PubMed ID: 17134736
[TBL] [Abstract][Full Text] [Related]
4. Foamy gland carcinoma of the prostate in needle biopsy: incidence, Gleason grade, and comparative α-methylacyl-CoA racemase vs. ERG expression.
Warrick JI; Humphrey PA
Am J Surg Pathol; 2013 Nov; 37(11):1709-14. PubMed ID: 23797726
[TBL] [Abstract][Full Text] [Related]
5. Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer.
Zhou M; Jiang Z; Epstein JI
Am J Surg Pathol; 2003 Jun; 27(6):772-8. PubMed ID: 12766580
[TBL] [Abstract][Full Text] [Related]
6. How often does alpha-methylacyl-CoA-racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers?
Zhou M; Aydin H; Kanane H; Epstein JI
Am J Surg Pathol; 2004 Feb; 28(2):239-43. PubMed ID: 15043314
[TBL] [Abstract][Full Text] [Related]
7. Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens.
Browne TJ; Hirsch MS; Brodsky G; Welch WR; Loda MF; Rubin MA
Hum Pathol; 2004 Dec; 35(12):1462-8. PubMed ID: 15619204
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical stains for p63 and alpha-methylacyl-CoA racemase, versus a cocktail comprising both, in the diagnosis of prostatic carcinoma: a comparison of the immunohistochemical staining of 430 foci in radical prostatectomy and needle biopsy tissues.
Hameed O; Sublett J; Humphrey PA
Am J Surg Pathol; 2005 May; 29(5):579-87. PubMed ID: 15832080
[TBL] [Abstract][Full Text] [Related]
9. Utility of ERG versus AMACR expression in diagnosis of minimal adenocarcinoma of the prostate in needle biopsy tissue.
Andrews C; Humphrey PA
Am J Surg Pathol; 2014 Jul; 38(7):1007-12. PubMed ID: 24705308
[TBL] [Abstract][Full Text] [Related]
10. Reliability of the 34βE12, keratin 5/6, p63, bcl-2, and AMACR in the diagnosis of prostate carcinoma.
Boran C; Kandirali E; Yilmaz F; Serin E; Akyol M
Urol Oncol; 2011; 29(6):614-23. PubMed ID: 20189848
[TBL] [Abstract][Full Text] [Related]
11. Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens.
Jiang Z; Li C; Fischer A; Dresser K; Woda BA
Am J Clin Pathol; 2005 Feb; 123(2):231-6. PubMed ID: 15842047
[TBL] [Abstract][Full Text] [Related]
12. Alpha-methylacyl coenzyme A racemase immunoreactivity in partial atrophy of the prostate.
Adley BP; Yang XJ
Am J Clin Pathol; 2006 Dec; 126(6):849-55. PubMed ID: 17074684
[TBL] [Abstract][Full Text] [Related]
13. Detection of alpha-methylacyl-coenzyme A racemase in postradiation prostatic adenocarcinoma.
Yang XJ; Laven B; Tretiakova M; Blute RD; Woda BA; Steinberg GD; Jiang Z
Urology; 2003 Aug; 62(2):282-6. PubMed ID: 12893336
[TBL] [Abstract][Full Text] [Related]
14. 34BetaE12 and Alfa-Methylacyl Coenzyme A Racemase (AMACR) Antibodies Better Than p63 Antibody Distinguish Normal and Neoplastic Glands in Prostatic Tissue With Thermal Artifacts.
Pierconti F; Rossi ED; Martini M; Sacco E; Bassi PF; Larocca LM
Appl Immunohistochem Mol Morphol; 2019 Apr; 27(4):306-310. PubMed ID: 29346181
[TBL] [Abstract][Full Text] [Related]
15. Alpha methylacyl-CoA racemase (AMACR) in prostate adenocarcinomas from Japanese patients: is AMACR a "race"-dependent marker?
Yamada H; Tsuzuki T; Maeda N; Yamauchi Y; Yoshida S; Ishida R; Nishikimi T; Yokoi K; Kobayashi H
Prostate; 2013 Jan; 73(1):54-9. PubMed ID: 22593005
[TBL] [Abstract][Full Text] [Related]
16. Application of alpha-methylacyl coenzyme A racemase immunohistochemistry in the diagnosis of prostate cancer: a review.
Adley BP; Yang XJ
Anal Quant Cytol Histol; 2006 Feb; 28(1):1-13. PubMed ID: 16566275
[TBL] [Abstract][Full Text] [Related]
17. alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer.
Rubin MA; Zhou M; Dhanasekaran SM; Varambally S; Barrette TR; Sanda MG; Pienta KJ; Ghosh D; Chinnaiyan AM
JAMA; 2002 Apr; 287(13):1662-70. PubMed ID: 11926890
[TBL] [Abstract][Full Text] [Related]
18. Small glandular proliferations on needle biopsies: most common benign mimickers of prostatic adenocarcinoma sent in for expert second opinion.
Herawi M; Parwani AV; Irie J; Epstein JI
Am J Surg Pathol; 2005 Jul; 29(7):874-80. PubMed ID: 15958851
[TBL] [Abstract][Full Text] [Related]
19. Comparison of annexin II, p63 and alpha-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study.
Stewart J; Fleshner N; Cole H; Sweet J
J Clin Pathol; 2007 Jul; 60(7):773-80. PubMed ID: 16916997
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic utility of p63 and α-methyl acyl Co A racemase in resolving suspicious foci in prostatic needle biopsy and transurethral resection of prostate specimens.
Singh V; Manu V; Malik A; Dutta V; Mani NS; Patrikar S
J Cancer Res Ther; 2014; 10(3):686-92. PubMed ID: 25313761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
